Terminal Latency Index, Residual Latency and Median Ulnar F Latency Difference in Carpal Tunnel Syndrome

Carpal Tunnel Syndrome Clinical Trial

Official title:

Role of Terminal Latency Index, Residual Latency and Median Ulnar F Latency Difference in Carpal Tunnel Syndrome

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03499158
• Other study ID #: KA15/280
• Status: Completed
• First received: April 11, 2018
• Last updated: April 13, 2018
• Start date: January 1, 2016
• Est. completion date: March 2, 2016

Study information

• Verified date: April 2018
• Source: Ufuk University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Terminal latency index, residual latency and median ulnar F latency difference in carpal tunnel syndrome are specific parameters for the diagnosis

Description:

Carpal tunnel syndrome is the most common compression neuropathy. This study was performed to determine the value of terminal latency index, residual latency and median ulnar F latency difference to investigate their sensitivity and specificity in the diagnosis of this syndrome.

We retrospectively determined the 160 patients. We evaluated the nerve conduction studies of patient and healthy arms. We recorded all nerve conduction study values.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 160
• Est. completion date: March 2, 2016
• Est. primary completion date: March 1, 2016
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 90 Years

Eligibility

Inclusion Criteria:

• Patients who had gone to electrodiagnostic study and diagnosed as carpal tunnel syndrome

Exclusion Criteria:

• any history of hereditary polyneuropathies

• acquired polyneuropathies

• surgery or local steroid injections for upper limbs or effect the study

• any history of fracture at the sites of stimulation or recording

Related Conditions & MeSH terms

• Carpal Tunnel Syndrome
• Syndrome

Intervention

Other:
• nerve conduction study
nerve conduction study

Locations

Country	Name	City	State
n/a

Sponsors (2)

Lead Sponsor	Collaborator
ASLIHAN UZUNKULAOGLU	Baskent University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	nerve conduction studies		one month